1. A composition comprising a therapeutically effective amount of a plant extract of Sanguisorbae officinalis and a plant extract of Ailanthus altissima for treating and / or preventing infection in a patient. The composition of claim 1, wherein the infection is secondary to chronic inflammation or atopic dermatitis (AD). The composition of claim 2, wherein said infection is associated with a disease selected from the group consisting of atopic disease, contact dermatitis, coin-shaped dermatitis, radiation dermatitis, burns, non-atopic eczema, bedsores, inflammatory eye disease, respiratory inflammatory diseases, asthma, gastrointestinal intestinal diseases and infectious diseases of the mouth. 4. The composition according to claim 1, where the therapeutically effective amount is intended to reduce the secretion of a Th2-type cytokine selected from the group consisting of IL-4, IL-5, IL-6, IL-10 and IL-13, in the cell of the specified patient. 5. The composition according to claim 1, wherein the therapeutically effective amount is intended to increase expression of human beta-defensin in the cell of said patient. The composition of claim 1, wherein the composition further comprises one or more of a plant extract of Galla rhois gallnut, a plant extract of Glycyrrhiza glabra, a plant extract of Rheum palmatum, a plant extract of Scutellaria baicalensis, a plant extract of Peucedanum praeruptorum, a plant extract of Cimicifuga mariumumomaosaosa raceosaosa, and dipotassium glycyrizate. 7. A composition comprising a therapeutically effective amount of a plant extract of Sanguisorbae officinalis and ailanton in a concentration of at least about 0.01% by weight. for the treatment and / or prevention of infection in a patient. 8. Composition �1. Композиция, содержащая терапевтически эффективное количество растительного экстракта Sanguisorbae officinalis и растительного экстракта Ailanthus altissima для лечения и/или профилактики инфекции у пациента.2. Композиция по п.1, где
